**8. References**


Acute Myocarditis – A Trigger of

Cardiac Autoimmunity? Expected Insights from the Etiology, Titre-Course… 399

Göser, S., Andrassy, M., Buss, S.J., Leuschner, F., Volz, C.H., Öttl, R., Zittrich, S., Blaudeck,

Harding, C.V., Unanue, E.R. & Slot, J.M. (1990). Functional and ultrastructural evidence for

Iwata, M., Yoshikawa, T., Baba, A., Anzai, T., Mitamura, H. & Ogawa, S. (2001).

Jahns, R., Boivin, V., Hein, L., Palm, D., Nikolaev, V.O., Müller, J., Angermann, C.E., Ertl, G.

Jahns, R, Boivin, V., Hein, L., Triebel, S., Angermann, C.E., Ertl, G & Lohse M.J. (2004).

cause of idiopathic dilated cardiomyopathy. *J. Clin. Invest.* 113:1419-1429. Jahns, R., Boivin, V. & Lohse, M.J. (2006). Beta1-adrenergic receptor function, autoimmunity, and pathogenesis of dilated cardiomyopathy. *Trends Cardiovasc. Med.* 16: 20-24. Jahns, R., Boivin, V., Inselmann, G., Lohse, M. & Boege, F. (1999). Autoantibodies activating

Jahns, R., Schlipp, A., Boivin, V. & Lohse, M.J. (2010). Targeting receptor-antibodies in

Kindermann, I., Kindermann, M., Kandolf, R., Klingel, K., Bultmann, B., Müller, T.,

Kühl, U., Noutsias, M., Seeberg, B. & Schultheiss, H.P. (1996). Immunohistological evidence

Kühl, U., Pauschinger, M., Noutsias, M., Seeberg, B., Bock, T., Lassner, D., Poller, W.,

Kühl, U., Pauschinger, M., Seeberg, B., Lassner, D., Noutsias, M., Poller, W. & Schultheiss,

Latif, N., Baker, C.S., Dunn, M.J., Keeling, P.J. & Botazzo, G.F. (1993). Frequency and

using SDS-page and Western blotting. *J. Am. Coll. Cardiol.* 22: 1378-1384. Li, Y., Heuser, J.S., Cunningham, L.C., Kosanke, S.D. & Cunningham, M.W. (2006). Mimicry

immune-cardiomyopathy. *Semin. Thromb. Hemost.* 36: 212-218.

dilated cardiomyopathy. *J. Am. Coll. Cardiol.* 37: 418-424.

the myocardium. *Circulation* 114: 1693-1702.

receptors. *Int. J. Cardiol.* 54: 103-111.

receptors. *Circulation* 112, suppl.II: 5 (120).

chronic heart failure. *Circulation* 99: 649-654.

myocarditis. *Circulation* 118,6: 639-648.

ventricular dysfunction. *Circulation* 111: 887-893.

cardiac dysfunction. *Circulation* 112: 1965-1970.

*Heart* 75,3: 295-300.

8234-8240.

N., Hardt, S.E., Pfitzer, G., Rose, N.R., Katus, H.A. & Kaya, Z. (2006). Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in

intracellular formation of major histocompatibility complex class II-peptide complexes during antigen processing. *Proc. Natl. Acad. Sci. USA* 87: 5553-5557. Hoebeke, J. (1996). Structural basis of autoimmunity against G protein-coupled membrane

Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic

& Lohse, M.J. (2005). A new cyclic receptor-peptide prevents development of heart dilatation and failure induced by antibodies activating cardiac beta1-adrenergic

Direct evidence for a beta1-adrenergic receptor directed autoimmune attack as a

human beta1-adrenergic receptors are associated with reduced cardiac function in

Lindinger, A. & Böhm, M. (2008). Predictors of outcome in patients with suspected

for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.

Kandolf, R. & Schultheiss, H.P. (2005). High prevalence of viral genomes and multiple viral infections in the myocardium of adults with idiopathic left

H.P. (2005). Viral persistence in the myocardium is associated with progressive

specificity of antiheart antibodies in patients with dilated cardiomyopathy detected

and antibody-mediated cell signaling in autoimmune myocarditis. *J. Immunol.* 177:

enhancing L-type Ca2+ current in rat ventricular myocytes. *J. Mol. Cell Cardiol.* 41: 716-723.


Cooper, L.T., Baughman, K.L., Feldman, A.M., Frustaci, A., Jessup, M., Kuhl, U., Levine,

Elies R., Ferrari I, Wallukat G, Lebesgue D, Chiale P, Elizari M, Rosenbaum M, Hoebeke J,

Elliott, P., Andersson, B., Arbustini, E., Bilinska, Z., Cecchi, F., Charron, P., Dubourg, O.,

Engelhardt, S., Hein, L., Dyachenkow, V., Kranias, E.G., Isenberg, G. & Lohse, M.J. (2004).

Eriksson, U., Ricci, R., Hunziker, L., Kurrer, M.O., Oudit, G.Y., Watts, T.H., Sonderegger, I.,

Felix, S.B. & Staudt, A. (2008). Immunoadsorption as a teatment option in dilated

Felix, S.B., Staudt, A., Landsberger, M., Grosse, Y., Stangl, V., Spielhagen, T., Wallukat, G.,

Freedman, N.J. & Lefkowitz, R.J. (2004). Anti-beta1-adrenergic receptor antibodies and heart

Frustaci, A., Russo, M.A. & Chimenti, C. (2009). Randomized study on the efficacy of

Fu, L.X.M., Magnusson, Y., Bergh, C.H., Waagstein, F., Hjalmarson, Å. & Hoebeke, J. (1993).

Fu, M. (2008). Autoimmunity and idiopathic dilated cardiomyopathy: where we stand?

Golden, B., Levin, L., Ban, Y., Concepcion, E., Greenberg, D.A. & Tomer, Y. (2005). Genetic

common and unique genes. *J. Clin. Endocrinol. Metab.* 90,8: 4904-4911.

failure: causation, not just correlation. *J. Clin. Invest.* 113: 1379-1382.

cardiomyopathy: the TIMIC study. *Eur. Heart J.* 30,16: 1995-2002.

dilated cardiomyopathy. *J. Clin. Invest.* 91: 1964-1968.

Society of Cardiology. *J. Am. Coll. Cardiol.* 50,19: 1914-1931.

Myocardial and Pericardial Diseases. *Eur. Heart J.* 29,2: 270-276.

beta-adrenergic stimulation. *Circulation* 109: 1154-1160.

immunity. *Nat. Med.* 9,12: 1484-1490.

cardiomyopathy. *Autoimmunity* 41,6: 484-489.

716-723.

4203-4211

39,4: 646-652.

*Autoimmunity* 41,6: 415-418.

enhancing L-type Ca2+ current in rat ventricular myocytes. *J. Mol. Cell Cardiol.* 41:

G.N., Narula, J., Starling, R.C., Towbin, J. & Virmani, R. (2007). The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European

Levin MJ (1996) Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J. Immunol. 157:

Kuhl, U., Maisch, B., McKenna, W.J., Monserrat, L., Pankuweit, S., Rapezzi, C., Seferovic, P., Tavazzi, L. & Keren, A. (2008). Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on

Altered calcium handling is critically involved in the cardiotoxic effects of chronic

Bachmaier, K., Kopf, M. & Penninger, J.M. (2003). Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate

Wernecke, K.D., Baumann, G. & Stangl, K. (2002). Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. *J. Am. Coll. Cardiol.*

immunosuppressive therapy in patients with virus-negative inflammatory

Localization of a functional autoimmune epitope on the second extracellular loop of the human muscarinic acetylcholine receptor 2 in patients with idiopathic

analysis of families with autoimmune diabetes and thyroiditis: evidence for


Acute Myocarditis – A Trigger of

nephritis. *Nat. Med.* 14: 748-755.

*Am. Coll. Cardiol.* 16: 839-846.

*Med.* 9,12: 1477-1483.

93,5: 841-842.

168: 2102-2109.

1396-1406.

603-617.

*Am. J. Cardiol.* 80: 1040-1045.

Cardiac Autoimmunity? Expected Insights from the Etiology, Titre-Course… 401

Neubert, K., Meister, S., Moser, K., Weisel, F., Maseda, D., Amann, K., Wiethe, C., Winkler,

Neumann, D.A., Burek, C.L., Baughman, K.L., Rose, N.R. & Herskowitz, A. (1990). Circula-

Nikolaev, V.O., Boivin, V., Störk, S., Angermann, C.E., Ertl, G., Lohse, M.J.& Jahns, R. (2007).

Noutias, M., Rohde, M., Göldner, K., Block, A., Blunert K., Hemaidan, L., Hummel M.,

Okazaki, T., Tanaka, Y., Nishio, R., Mitsuiye, T., Mizoguchi, A., Wang, J., Ishida, M., Hiai,

Pohlner, K., Portig, I., Pankuweit, S., Lottspeich, F. & Maisch, B. (1997). Identification of

Richardson, P., McKenna, W., Bristow, M., Maisch, B., Mautner, B., O'Connell, J., Olsen, E.,

Rose, N.R. (2001). Infection, mimics, and autoimmune disease. *J. Clin. Invest.* 107: 943-944. Schultheiss, H.P. & Bolte, H.D. (1985). Immunological analysis of autoantibodies against the

Schultheiss, H.P., Kühl, U., Janda, I., Melzner, B., Ulrich, G. & Morad, M. (1988). Antibody-

Schulze, K., Witzenbichler, B., Christmann, C. & Schultheiss, H.P. (1999). Disturbance of

against the adenine nucleotid translocator. *Cardiovasc. Res.* 44: 91-100. Smulski, C., Labovsky, V., Levy, G., Hontebeyrie, M., Hoebeke, J. & Levin, M.J. (2006).

receptor autoantibodies in heart failure. *J. Am. Coll. Cardiol.* 50: 423-431. Noutsias, M., Seeberg, B., Schultheiss, H.P. & Kühl, U. (1999). Expression of cell adhesion

inflammatory cardiomyopathy. *Circulation* 99,16: 2124-2131.

dilated cardiomyopathy. *Eur. J. Heart Fail.* 13,6: 611-618.

T.H., Kalden, J.R., Manz, R.A. & Voll, R.E. (2008). The proteasome inhibitor bortezemib depletes plasma cells and protects mice with lupus-like disease from

ting heart-reactive antibodies in patients with myocarditis or cardiomyopathy. *J.* 

A novel fluorescent method for the rapid detection of functional beta1-adrenergic

molecules in dilated cardiomyopathy: evidence for endothelial activation in

Blohm, J.H., Lassner, D., Kühl, U. , Schultheiss, H.P., Volk, H.D. & Kotsch, K. (2011). Expression of functional T cell markers and T cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and

H., Matsumori, A., Minato, N. & Honjo, T. (2003). Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. *Nat.* 

mitochondrial antigens recognized by the antibody in sera of patients with dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing.

Thiene, G., Goodwin, J., Gyarfas, I., Martin, I.& Nordet, P. (1996). Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. *Circulation*

adenine nucleotide translocator in dilated cardiomyopathy. *J. Mol. Cell Cardiol.* 17:

mediated enhancement of calcium permeability in cardiac myocytes. *J. Exp. Med.*

myocardial energy metabolism in experimental virus myocarditis by antibodies

Structural basis of the cross-reaction between an antibody to the trypanosoma cruzi ribosomal P2beta protein and the human beta1-adrenergic receptor. *FASEB J.* 20:


Limas, C.J. (1996). Autoimmunity in DCM and the major histocompatibility complex. *Int. J.* 

Limas, C.J. (1997). Cardiac autoantibodies in dilated cardiomyopathy. *Circulation* 95: 1979-

Limas, C.J., Goldenberg, I.F. & Limas, C. (1992). Assessment of immune modulation of beta-

Limas, C.J., Iakovis, P., Anyfantakis, A., Kroupis, C. & Cokkinos, D.V. (2004). Familial

Liu, P. & Mason, J. (2001). Advances in the understanding of myocarditis. *Circulation* 104:

Luppi, P., Rudert, W.A., Zanone, M.M., Stassi, G., Trucco, G., Finegold, D., Boyle, G.J., Del

Maekawa, Y., Ouzounian, M., Opavsky, M.A. & Liu, P.P. (2007). Connecting the missing link between dilated cardiomyopathy and viral myocarditis. *Circulation* 115: 5-8. Magnusson, Y., Hjalmarson, Å. & Hoebeke, J. (1996). Beta1-adrenoceptor autoimmunity in

Magnusson, Y., Wallukat, G., Waagstein, F., Hjalmarson, Å. & Hoebeke, J. (1994).

Maron, B.J., Towbin, J.A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A.J.,

Matsui, S., Fu, M., Hayase, M., Katsuda, S., Yamaguchi, N., Teraoka, K., Kurihara, T.W.,

Müller, I.I., Klingel, K., Nikolaev, V.O., Jahns, R., Gawatz, M.P. & Weig, H.J. (2008).

mice induces cardiomyopathic changes. *Autoimmunity* 39,2: 121-128. Mobini, R., Magnusson, Y., Wallukat, G., Viguier, M., Hjalmarson, Å. & Hoebeke, J. (1999).

underlying active myocarditis. *Clin. Res. Cardiol.* 22: 138-140.

Epidemiology and Prevention. *Circulation* 113: 1807-1816.

beta1-adrenoceptor. *J. Autoimmun.* 13,2: 179-186.

Autoimmunity in idiopathic DCM. Characterization of antibodies against the beta1-adrenoceptor with positive chronotropic effect. *Circulation* 89,6: 2760-2767. Mahrholdt, H., Wagner, A., Deluggi, C.C., Kispert, E., Hager, S., Meinhardt, G., Vogelsberg,

H., Fritz, P., Dippon, J., Bock, C.-T., Klingel, K., Kandolf, R. & Sechtem, U. (2006). Presentation, patterns of myocardial damage, and clinical course of viral

Seidman, C.E. & Young, J.B. (2006). Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on

Murano, H. & Takekoshi, N. (2006). Transfer of immune components from rabbit autoimmune cardiomyopathy into severe combined immunodeficiency (SCID)

Probing the immunological properties of the extracellular domains of the human

Immunoadsorption in a 40 year old man with dilated cardiomyopathy and

A superantigen-driven autoimmune disease. *Circulation* 98: 777-785. MacLellan, W.R. & Lusis, A.J. (2003). Dilated cardiomyopathy: learning to live with yourself.

adrenergic pathways in human dilated cardiomyopathy: influence of methodologic

clustering of autoimmune diseases in patients with dilated cardiomyopathy. *Am. J.* 

Nido, P., McGowan, F.X. & Trucco, M. (1998). Idiopathic dilated cardiomyopathy.

*Cardiol.* 54: 113-116.

*Cardiol.* 93: 1189-1191.

*Nat. Med.* 9: 1455-1456.

cardiomyopathy. *Int. J. Cardiol.* 54: 137-141.

myocarditis. *Circulation* 114: 1581-1590.

1076-1082.

factors. *Am. Heart J.* 123: 967-970.

1980.


**20** 

Decheng Yang

*Canada* 

**Nucleic Acid-Based Strategies for the Treatment** 

Viral myocarditis is the most common heart disease in infants, children, young adults and pregnant women. Although a number of viruses from different genera, such as adenovirus, hepatitis C virus (HCV), parvoviruses and cytomegalovirus have been reported to cause myocarditis (Bowles et al., 2003; Kindermann et al., 2008; Kuhl et al., 2005a; Kuhl et al., 2005b; Kyto et al., 2005; Mahrholdt et al., 2006; Matsumori, 2005; Matsumori et al., 2006), coxsackievirus, particularly coxsackievirus B3 (CVB3), is generally considered the primary etiological agent of myocarditis (Blauwet, 2010; Kuhl et al., 2005a; Mahrholdt et al., 2006). CVB3 infection of the heart is often persistent and enters the chronic phase, leading to dilated cardiomyopathy (DCM)(Andreoletti et al., 2009; L. T. Cooper, Jr., 2009; Kuhl et al., 2005b; Yajima& Knowlton, 2009), a squelae of viral myocarditis characterized by ventricular chamber dilation, increased wall thickness, weaker beating and abnormal heart function.

To date, there is no clinically proven specific treatment available for viral myocarditis and DCM. Patients with DCM eventually need heart transplantation as the final treatment (Schultz et al., 2009). The managements for viral myocarditis are usually supportive therapies, such as improvements in cardiophysiology with medicine used to treat other kinds of heart diseases, and application of non-specific antiviral agents to decrease the viral load. The former measurements include administration of angiotensin-converting enzyme inhibitor or angiotensin receptor blockade, beta-adrenergic blockade, diuretics, etc (Dennert et al., 2008; Rose, 2009; Schultz et al., 2009); the later measurements include application of type I interferons or nucleotide analogs such as ribavirin, which is reviewed elsewhere (Blauwet, 2010; Dennert& Crijns& Heymans, 2008; Schultz et al., 2009). If myocarditis was caused by an autoimmune disorder, it would be appropriately treated by immunosuppression (Rose, 2009; Schultz et al., 2009). However, the effectiveness of treatment with immunosuppressive therapies has not reached a consensus amongst different studies. This can probably be attributed to the difficulty of confirmation and diagnosis of the etiology and pathogenesis of myocarditis. Thus it is very important to distinguish infectious and autoimmune disease since the same methods of treatment will not be optimal for both forms of heart muscle diseases. The diagnostic gold standard is endomyocardial biopsies with the histological Dallas criteria, in association with new

Patients with DCM eventually develop into congestive heart failure.

**1. Introduction** 

*Department of Pathology and Laboratory Medicine, University of British Columbia, The Institute for Heart and Lung Health, St. Paul's Hospital, Vancouver, B. C.,* 

**of Coxsackievirus-Induced Myocarditis** 

